P/E ratio for Haemonetics (HAE)
P/E ratio as of April 2025 (TTM): 24.0
According to Haemonetics's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 24.0303. At the end of 2022 the company had a P/E ratio of 41.8.
P/E ratio history for Haemonetics from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 41.8 | -65.87% |
| 2021 | 123 | 120.82% |
| 2020 | 55.5 | -24.18% |
| 2019 | 73.2 | -34.55% |
| 2018 | 112 | -165.46% |
| 2017 | -171 | -234.9% |
| 2016 | 127 | -487.6% |
| 2015 | -32.7 | -151.15% |
| 2014 | 63.9 | 10.27% |
| 2013 | 57.9 | 21.76% |
| 2012 | 47.6 | 112.9% |
| 2011 | 22.3 | -10.88% |
| 2010 | 25.1 | 21.38% |
| 2009 | 20.7 | -15.18% |
| 2008 | 24.4 | -13.82% |
| 2007 | 28.3 | 8.6% |
| 2006 | 26.0 | 23.56% |
| 2005 | 21.1 | -9.85% |
| 2004 | 23.4 | -2.21% |
| 2003 | 23.9 | 42.49% |
| 2002 | 16.8 | -43.8% |
| 2001 | 29.8 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 | 28.5 | 18.80% | 🇺🇸 USA |
 | 50.8 | 111.31% | 🇺🇸 USA |
 | 37.4 | 55.46% | 🇺🇸 USA |
 | -4.28 | -117.79% | 🇺🇸 USA |
 | 5.62 | -76.60% | 🇺🇸 USA |
 | 15.0 | -37.72% | 🇺🇸 USA |
 | 10.9 | -54.73% | 🇺🇸 USA |
 | 30.5 | 26.80% | 🇮🇪 Ireland |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.